Invesco’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,061,560
| Closed | -$4.25M | – | 3808 |
|
|
2019
Q4 | $4.25M | Buy |
1,061,560
+50,204
| +5% | +$236K | ﹤0.01% | 2258 |
|
|
2019
Q3 | $4.96M | Sell |
1,011,356
-209,198
| -17% | -$1.17M | ﹤0.01% | 2130 |
|
|
2019
Q2 | $7.43M | Buy |
1,220,554
+424,647
| +53% | +$2.26M | ﹤0.01% | 1942 |
|
|
2019
Q1 | $4.62M | Buy |
795,907
+52,031
| +7% | +$537K | ﹤0.01% | 2062 |
|
|
2018
Q4 | $10M | Sell |
743,876
-176,405
| -19% | -$2.97M | ﹤0.01% | 1536 |
|
|
2018
Q3 | $17.9M | Buy |
920,281
+410,630
| +81% | +$8.74M | 0.01% | 1357 |
|
|
2018
Q2 | $13M | Buy |
509,651
+228,304
| +81% | +$5.32M | ﹤0.01% | 1510 |
|
|
2018
Q1 | $5.67M | Buy |
281,347
+78,019
| +38% | +$1.82M | ﹤0.01% | 1880 |
|
|
2017
Q4 | $4.08M | Buy |
203,328
+15,142
| +8% | +$298K | ﹤0.01% | 2120 |
|
|
2017
Q3 | $3.9M | Buy |
188,186
+11,390
| +6% | +$193K | ﹤0.01% | 2125 |
|
|
2017
Q2 | $2.62M | Buy |
176,796
+2,914
| +2% | +$48.6K | ﹤0.01% | 2357 |
|
|
2017
Q1 | $2.77M | Buy |
173,882
+56,911
| +49% | +$821K | ﹤0.01% | 2362 |
|
|
2016
Q4 | $1.47M | Sell |
116,971
-30,886
| -21% | -$575K | ﹤0.01% | 2783 |
|
|
2016
Q3 | $4.14M | Buy |
147,857
+37,892
| +34% | +$1.27M | ﹤0.01% | 2099 |
|
|
2016
Q2 | $3.85M | Buy |
109,965
+5,090
| +5% | +$160K | ﹤0.01% | 2096 |
|
|
2016
Q1 | $2.87M | Buy |
+104,875
| New | +$3.09M | ﹤0.01% | 2242 |
|
|
2015
Q3 | – | Sell |
-855
| Closed | -$38K | – | 4123 |
|
|
2015
Q2 | $38K | Buy |
+855
| New | +$32.2K | ﹤0.01% | 3997 |
|
Other funds holding DPLO
Invesco's DPLO Position: Q1 2020 in Review
Invesco sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 1,061,560 shares — an estimated $4.25M sold.
Invesco first reported a position in DPLO in Q2 2015 and held it in 17 quarters. The position peaked at $17.9M in Q3 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Invesco reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Invesco sold 1,061,560 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $4.25M.
- Invesco first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 17 quarters.
- Invesco's DIPLOMAT PHARMACY, INC. position peaked at $17.9M in Q3 2018.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Invesco's 13F filing for Q1 2020, filed 15 May 2020.